Safe Group Approves All Resolutions at General Meeting
Shareholders of Safe Group approved all the resolutions submitted at the general meeting held on December 26 in Fleurieux-sur-l'Arbresle, according to the company. The participation rate was 26.82%.
Unanimous Approval by the General Meeting
The mixed general meeting of Safe Group, a French specialist in medical technologies, approved all the resolutions presented by the board of directors. The meeting, chaired by Victor Humberdot, chairman of the board, recorded a quorum of 26.82%, according to the press release.
Commitment to Shareholder Dialogue and Engagement
Following this meeting, the board of directors reaffirmed its commitment to continue its policy of dialogue and shareholder engagement, initiated in December 2023, the press release states. This approach reflects the group's desire to maintain an ongoing relationship with its shareholders. Safe Group did not disclose the specific details of implementing this policy.
Overview of Safe Group's Operations
Safe Group comprises Safe Orthopaedics, specializing in ready-to-use technologies for spinal pathologies, and Safe Medical, formerly LCI Medical, a subcontractor of medical devices for orthopedic surgery. The group employs about 100 staff members. Safe Orthopaedics distributes kits combining sterile implants and single-use instruments, protected by 14 patent families. These products are CE marked and approved by the FDA. The group has subsidiaries in the United Kingdom, Germany, and the United States. Safe Medical operates two production sites, in France at Fleurieux-sur-l'Arbresle and in Tunisia.
